71/100Bargenx stock forecast 2026–2030
Analysts' average 12-month price target for argenx is 1,133.33, 22.1% above the current price of 928.52. Their targets range from 861.00 to 1,400.00.
Of the 18 firms that rated argenx in the past 12 months, 16 rate it buy or strong buy, 2 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 861.00 to 1,400.00, with an average of 1,133.33.
| Strong buy | 0 | |
| Buy | 16 | |
| Hold | 2 | |
| Sell | 0 | |
| Strong sell | 0 |
12-month price target
| Highest target | 1,400.00 |
| Average target | 1,133.33 |
| Lowest target | 861.00 |
| Current price | 928.52 |
argenx price target history
Have analysts recently raised or lowered their argenx price target and rating?
How analysts rate argenx, month by month
16 of 18 firms rate it buy now, against 17 of 19 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
argenx analyst upgrades, downgrades and price targets
The latest rating change came on 26 August 2026, when UBS upgraded argenx from Neutral to Buy. Its price target is 1,400.00, from 910.00. The most recent new target came from Morgan Stanley on 23 October 2026: 1,190.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 23 Oct 2026 | Morgan Stanley Sean Laaman | Reiterated · Overweight | 1,140.00 → 1,190.00 | +4.4% | 875.76 |
| 23 Oct 2026 | Guggenheim | Reiterated · Buy | 1,185.00 → 1,120.00 | -5.5% | 875.76 |
| 23 Oct 2026 | Robert W. Baird Collen Kusy | — | 823.00 → 861.00 | +4.6% | 875.76 |
| 23 Oct 2026 | Wells Fargo | Reiterated · Overweight | 1,356.00 → 1,336.00 | -1.5% | 875.76 |
| 22 Oct 2026 | Stifel Nicolaus Alex Thompson | — | 1,282.00 → 1,200.00 | -6.4% | 886.47 |
| 14 Oct 2026 | Wells Fargo | Reiterated · Overweight | 1,355.00 → 1,356.00 | +0.1% | 802.64 |
| 12 Oct 2026 | Oppenheimer Leland Gershell | Reiterated · Outperform | 1,100.00 → 1,038.00 | -5.6% | 822.29 |
| 9 Oct 2026 | Morgan Stanley | — | 1,250.00 → 1,140.00 | -8.8% | 815.86 |
| 9 Oct 2026 | Evercore ISI | Reiterated · Outperform | 910.00 → 1,078.00 | +18.5% | 817.51 |
| 9 Oct 2026 | Robert W. Baird Collen Kusy | — | 932.00 → 823.00 | -11.7% | 818.63 |
| 9 Oct 2026 | Wells Fargo Derek Archila | — | 1,415.00 → 1,355.00 | -4.2% | 818.63 |
| 8 Oct 2026 | Stifel Nicolaus Alex Thompson | — | 1,255.00 → 1,282.00 | +2.2% | 795.70 |
| 31 Aug 2026 | Morgan Stanley | Reiterated · Overweight | 1,230.00 → 1,250.00 | +1.6% | 1,023.21 |
| 26 Aug 2026 | Wells Fargo Derek Archila | Reiterated · Overweight | 1,350.00 → 1,415.00 | +4.8% | 1,019.49 |
| 26 Aug 2026 | UBS Xian Deng | Upgraded · Neutral → Buy | 910.00 → 1,400.00 | +53.8% | 1,019.49 |
| 18 Aug 2026 | Morgan Stanley | Reiterated · Overweight | 1,200.00 → 1,230.00 | +2.5% | 989.79 |
| 18 Aug 2026 | Wedbush | Reiterated · Outperform | 1,050.00 → 1,150.00 | +9.5% | 987.84 |
| 18 Aug 2026 | Oppenheimer | — | 1,037.00 → 1,100.00 | +6.1% | 987.84 |
| 18 Aug 2026 | RBC Capital Luca Issi | Reiterated · Outperform | 1,025.00 → 1,100.00 | +7.3% | 987.84 |
| 18 Aug 2026 | Truist Financial Danielle Brill | Reiterated · Buy | 1,030.00 → 1,095.00 | +6.3% | 987.84 |
| 18 Aug 2026 | H.C. Wainwright | — | 940.00 → 1,202.00 | +27.9% | 987.84 |
| 17 Aug 2026 | Piper Sandler | Reiterated · Overweight | 930.00 → 1,215.00 | +30.6% | 851.29 |
| 28 Jul 2026 | Wedbush | Reiterated · Outperform | 880.00 → 1,050.00 | +19.3% | 878.42 |
| 27 Jul 2026 | Robert W. Baird | — | 858.00 → 932.00 | +8.6% | 918.22 |
| 24 Jul 2026 | Barclays | — | 950.00 | — | 918.80 |
| 24 Jul 2026 | Morgan Stanley | — | 1,180.00 → 1,200.00 | +1.7% | 916.69 |
| 24 Jul 2026 | Oppenheimer | Reiterated · Outperform | 1,037.00 | — | 923.26 |
| 24 Jul 2026 | Leerink Partners | — | 1,065.00 | — | 924.60 |
| 24 Jul 2026 | Guggenheim | Reiterated · Buy | 1,135.00 → 1,185.00 | +4.4% | 924.60 |
| 24 Jul 2026 | Wells Fargo | — | 1,291.00 → 1,350.00 | +4.6% | 924.60 |
| 23 Jul 2026 | RBC Capital | — | 945.00 → 1,025.00 | +8.5% | 924.60 |
| 7 Jul 2026 | RBC Capital | Reiterated · Outperform | 890.00 → 945.00 | +6.2% | 916.80 |
| 24 Jun 2026 | RBC Capital Luca Issi | — | 925.00 → 890.00 | -3.8% | 855.84 |
| 24 Jun 2026 | Morgan Stanley Sean Laaman | Reiterated · Overweight | 1,170.00 → 1,180.00 | +0.9% | 869.41 |
| 4 Jun 2026 | H.C. Wainwright Douglas Tsao | — | 915.00 → 940.00 | +2.7% | 813.14 |
| 1 Jun 2026 | Wells Fargo | Reiterated · Overweight | 1,260.00 → 1,291.00 | +2.5% | 835.99 |
| 28 May 2026 | Stifel Nicolaus Alex Thompson | — | 1,222.00 → 1,255.00 | +2.7% | 838.49 |
| 8 May 2026 | Morgan Stanley Sean Laaman | — | 1,160.00 → 1,170.00 | +0.9% | 788.73 |
| 8 May 2026 | Guggenheim Yatin Suneja | Reiterated · Buy | 1,160.00 → 1,135.00 | -2.2% | 787.31 |
| 8 May 2026 | Wells Fargo | Reiterated · Overweight | 1,317.00 → 1,260.00 | -4.3% | 787.31 |
| 7 May 2026 | Stifel Nicolaus | — | 1,227.00 → 1,222.00 | -0.4% | 784.96 |
| 26 Feb 2026 | Stifel Nicolaus Alex Thompson | — | 1,248.00 → 1,227.00 | -1.7% | 769.98 |
| 20 Jan 2026 | Wells Fargo | Reiterated · Overweight | 1,317.00 | — | 800.01 |
| 8 Jan 2026 | Truist Financial Danielle Brill | Reiterated · Buy | 1,030.00 | — | 822.94 |
| 8 Jan 2026 | Morgan Stanley Sean Laaman | — | 1,110.00 → 1,160.00 | +4.5% | 822.94 |
| 18 Dec 2025 | Guggenheim Yatin Suneja | — | 1,160.00 | — | 850.57 |
| 18 Dec 2025 | Needham | — | 1,006.00 | — | 862.05 |
| 18 Dec 2025 | Robert W. Baird Collen Kusy | — | 924.00 → 858.00 | -7.1% | 862.05 |
| 18 Dec 2025 | Baird | Downgraded · Outperform → Neutral | — | — | — |
| 17 Dec 2025 | RBC Capital | Reiterated · Outperform | 850.00 → 925.00 | +8.8% | 863.37 |
argenx EPS and revenue estimates
Revenue
EPS
Does argenx beat earnings estimates?
On average, analysts' EPS estimate was 141.9% off the result, either way, and their revenue estimate 81.4%, over the last 12 quarters.
- EPS beats
- 17 / 25
- Revenue beats
- 15 / 25
- Average EPS surprise, last 12
- +134.1%
- Since
- November 2014
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| H1 FY2026 | 30 Jul 2026 | 7.44 | 7.80 | +4.8% | 1.66B | 2.82B | +69.6% |
| H1 FY2026 | 7 May 2026 | 5.16 | 5.90 | +14.3% | 1.45B | 3.21B | +121.8% |
| H2 FY2025 | 30 Oct 2025 | 4.37 | 5.18 | +18.5% | 1.28B | 947.96M | -25.7% |
| H1 FY2025 | 8 May 2025 | 2.32 | 2.58 | +11.2% | 861.83M | 573.24M | -33.5% |
| H2 FY2024 | 31 Oct 2024 | 0.10 | 1.39 | +1,290.0% | 665.08M | 401.00M | -39.7% |
| H1 FY2024 | 9 May 2024 | -0.71 | -1.04 | -46.5% | 563.91M | 329.79M | -41.5% |
| H2 FY2023 | 31 Oct 2023 | -1.54 | -1.25 | +18.8% | 279.81M | 510.92M | +82.6% |
| H1 FY2023 | 4 May 2023 | -2.34 | -0.57 | +75.5% | 174.28M | 312.69M | +79.4% |
| H1 FY2022 | 28 Jul 2022 | -4.83 | -4.26 | +11.8% | 25.86M | 111.36M | +330.5% |
| H2 FY2021 | 21 Mar 2022 | -4.87 | -4.36 | +10.5% | 18.07M | 26.81M | +48.4% |
| H2 FY2021 | 28 Oct 2021 | -4.42 | 1.17 | +126.5% | 320.06M | 470.40M | +47.0% |
| H1 FY2021 | 14 May 2021 | -2.59 | -0.67 | +74.1% | 36.25M | 15.51M | -57.2% |
argenx stock price 2026–2030: scenarios
If argenx's earnings keep growing at the 82.1% a year analysts expect to FY2028, it would earn about 155.57 a share in FY2030. At the P/E it has traded at over the last five years (39.8 to 44.2) that is 6,188.77 to 6,873.45 a share, or 6,531.11 at its average P/E of 42.0. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 28.47 | 1,132.40 | 1,195.04 | 1,257.68 |
| FY2027 | 37.21 | 1,480.22 | 1,562.10 | 1,643.99 |
| FY2028 | 46.89 | 1,865.41 | 1,968.59 | 2,071.78 |
| FY2029 (extrapolated) | 85.41 | 3,397.73 | 3,585.68 | 3,773.63 |
| FY2030 (extrapolated) | 155.57 | 6,188.77 | 6,531.11 | 6,873.45 |
Each year's EPS is the analysts' consensus to FY2028; the years after continue its 82.1% a year. Bear, base and bull apply the lowest, average and highest P/E of the last five fiscal year ends (39.8, 42.0, 44.2).
Most undervalued US stocks
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 195.09146Price 99.09244 | +96.9% | |
| 186.680 | 359.93270Price 186.68450 | +92.8% | |
| 213.670 | 405.66304Price 213.67507 | +89.9% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 42.225 | 79.0244Price 42.23157 | +87.1% | |
| 160.650 | 299.85225Price 160.65375 | +86.6% | |
| 108.445 | 201.41108Price 108.45248 | +85.7% |
Furthest below the fair value on each stock's page, updated every day.